Regeneron
Medicine, science, health, global
- B2B
- Has physical offices
- Publicly traded
- Manufacturing
- Sales-led purchase
About Regeneron
Develops and commercializes life-transforming medicines for serious diseases, establishing new approaches in science, manufacturing, and health. Building a future in biopharmaceuticals.
Key facts
- Industry
- Biotechnology
- Company size
- 10,000+ employees
- Headquarters
- Tarrytown, New York, United States
- Revenue
- $14.3BFY2025, publicly reported
- Website
- regeneron.com
Jobs at Regeneron
- Senior Product Manager, Predictive Analytics
- Executive Director: Data Management, Analytics, AI & Architecture
- Director Integrated Data Quality
- Director, Data Management Process, Quality & Inspection Readiness
- VP Enterprise Data & Information Management
- Director, Data Governance and Contract Compliance, Regeneron Genetics Center (RGC)
- Director Quality Assurance, Drug Substance Manufacturing
- Executive Director - Data Management, Analytics, AI & Architecture
Regeneron in the news
- Regeneron: The Easy Money Has Been Made (Rating Downgrade) (NASDAQ:REGN)
Regeneron Pharmaceuticals has been downgraded to 'Hold' as its stock is now considered appropriately priced, despite strong performance from DUPIXENT and EYLEA HD, but faces R&D setbacks.
- Sanofi Deepens 20-Year Drug Development Pact With Regeneron, Pledges Up to $8 Billion
Sanofi has deepened its 20-year drug development partnership with Regeneron, pledging up to $8 billion and focusing on new therapeutic programs building on the success of Dupixent.
- EASD 2026: Regeneron’s muscle preserver shows benefit at lower doses
Regeneron's muscle preserver drug was shown to be beneficial at lower doses during EASD 2026.
- #EASD26: Regeneron sees a future combining its obesity drug with lipid-lowering therapy
Regeneron is exploring combining its obesity drug with a lipid-lowering therapy to enter the competitive GLP-1 market.
- Regeneron Phase II trial confirms trevogrumab halves muscle loss
Regeneron's drug trevogrumab halved muscle loss in a Phase II trial for obesity patients, leading to plans for further trials.
Regeneron at a glance
Regeneron is a B2B company in the Biotechnology industry, headquartered in Tarrytown, New York, United States.
Regeneron has 10,000+ employees.
Regeneron's revenue is $14.3B (FY2025, publicly reported).
Regeneron is hiring: 8 recent open roles, including Senior Product Manager, Predictive Analytics, Executive Director: Data Management, Analytics, AI & Architecture, Director Integrated Data Quality.
Selling to companies like Regeneron?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies